M02.29 identifies postimmunization arthropathy affecting multiple joint sites simultaneously — a reactive joint condition that develops following vaccination rather than from direct pathogen invasion of the joint.
Verified May 8, 2026 · 4 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 10
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M02.29.
Source · Editorial brief grounded in 4 cited references ↓
- Document which specific joints are affected by name and side — 'bilateral wrists, right ankle, and left knee' is sufficient to support M02.29; 'multiple joints' alone is thin but defensible.
- Record the vaccine administered, the date of immunization, and the onset of joint symptoms — the temporal relationship is the clinical basis for this code.
- Note the absence of direct infection: cultures negative, synovial fluid non-purulent, or inflammatory markers consistent with reactive rather than septic arthritis.
- If a triggering condition such as infective endocarditis or viral hepatitis is identified, sequence that diagnosis first — document it explicitly so sequencing is unambiguous.
- Distinguish polyarticular involvement from migratory arthritis; if symptoms resolved completely in one joint before appearing in another, reconsider whether 'multiple sites' is accurate at the time of the encounter.
Related CPT procedures
Procedure codes commonly billed with M02.29. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M02.29 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M02.29 when only one joint is affected — select the site-specific M02.2x1/2/9 code instead; 'multiple sites' requires documented polyarticular involvement.
- Sequencing M02.29 first when an underlying triggering condition (e.g., viral hepatitis B15–B19) is identified — that condition must be coded first per the 'Code first' instruction at the M02 category level.
- Confusing postimmunization arthropathy with post-infectious reactive arthritis (M02.1x); the former follows vaccination, the latter follows a systemic infection such as enteric or genitourinary illness.
- Applying an Excludes1-listed code alongside M02.29 — rubella arthritis (B06.82), mumps arthritis (B26.85), and postmeningococcal arthritis (A39.84) cannot be coded simultaneously with any M02.2x code.
- Defaulting to M02.20 (unspecified site) when the record clearly documents multiple named joints — M02.29 is more specific and the better choice when multi-site involvement is explicit.
Clinical context
Source · Editorial summary grounded in 4 cited references ↓
Use M02.29 when a patient presents with joint inflammation at two or more anatomically distinct sites that is temporally and causally linked to a prior vaccination. The pathophysiology is immune-mediated, not infectious — the vaccine antigen triggers a systemic reactive arthropathy rather than seeding the joint directly. Common vaccine associations include influenza, hepatitis B, and rubella-containing vaccines, though the code does not specify the offending immunization.
M02.29 sits under parent code M02.2 (Postimmunization arthropathy) and is the correct choice when polyarticular involvement is documented. If only one joint is affected, choose a site-specific sibling code (e.g., M02.211 for the right shoulder, M02.261 for the right knee). If the provider documents joint inflammation after vaccination but doesn't specify which sites, use M02.20 (unspecified site) — not M02.29.
The M02 category carries an Excludes1 note barring simultaneous use with direct joint infection codes (M01.-), Behçet's disease (M35.2), postmeningococcal arthritis (A39.84), mumps arthritis (B26.85), rubella arthritis (B06.82), late syphilitic arthritis (A52.77), rheumatic fever (I00), and tabetic arthropathy (A52.16). If the arthropathy is driven by an identifiable underlying condition such as infective endocarditis (I33.0) or viral hepatitis (B15–B19), code that condition first and sequence M02.29 as an additional code.
Sibling codes
Other billable codes under M02.2 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 4 cited references ↓
01How many joints need to be affected to use M02.29 instead of a site-specific M02.2 code?
02Does M02.29 require a specific vaccine to be named in the record?
03Can M02.29 be coded alongside rubella arthritis (B06.82) if the patient had a rubella-containing vaccine?
04What is the correct sequencing when an underlying condition like viral hepatitis triggers the arthropathy?
05Is M02.29 valid for an initial visit and follow-up visits alike?
06How does M02.29 differ from M02.20?
07Can M02.29 be used for SIRVA (Shoulder Injury Related to Vaccine Administration)?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (FY2026, effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M00-M02/M02-/M02.29
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M02.29
- 04aapc.comhttps://www.aapc.com/codes/icd-10-codes/M02.2
Mira AI Scribe
Mira's AI scribe captures the specific joints involved, the vaccine name and administration date, and the onset timeline of joint symptoms — the three elements that anchor M02.29 and distinguish it from unspecified or single-site codes. Without documented polyarticular involvement and a clear vaccination link, the claim is vulnerable to downcoding to M02.20 or a non-specific arthropathy code.
See how Mira captures M02.29 documentation